(Q38395457)

2 September 2017

title

Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study (English)

1 reference

2 September 2017

1 reference

5

Masafumi Kurosumi

1 reference

2 September 2017

4

Hitoshi Tsuda

1 reference

2 September 2017

9

Hironobu Sasano

1 reference

2 September 2017

7

Rie Horii

1 reference

2 September 2017

8

Masakazu Toi

1 reference

2 September 2017

1

Yoshiki Mikami

1 reference

2 September 2017

Takayuki Ueno

2

1 reference

2 September 2017

Kenichi Yoshimura

series ordinal

3

1 reference

2 September 2017

Shinobu Masuda

series ordinal

6

1 reference

2 September 2017

publication date

6 September 2013

1 reference

2 September 2017

1 reference

2 September 2017

volume

104

1 reference

2 September 2017

issue

11

1 reference

2 September 2017

page(s)

1539-1543

1 reference

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

2 September 2017

cites work

1 reference

Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment

21 January 2018

1 reference

Ki67 in breast cancer: prognostic and predictive potential

21 January 2018

1 reference

A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer.

21 January 2018

1 reference

Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.

21 January 2018

1 reference

Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer.

21 January 2018

1 reference

Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast

21 January 2018

1 reference

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

21 January 2018

1 reference

Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer

21 January 2018

1 reference

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

21 January 2018

1 reference

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens

21 January 2018

1 reference

What causes discrepancies in HER2 testing for breast cancer? A Japanese ring study in conjunction with the global standard

21 January 2018

1 reference

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

Comparing methods of measurement: why plotting difference against standard method is misleading.

21 January 2018

1 reference

Developments in Ki67 and other biomarkers for treatment decision making in breast cancer.

21 January 2018

1 reference

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

21 January 2018

1 reference

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

21 January 2018

1 reference

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer.

21 January 2018

1 reference

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

21 January 2018

1 reference

Proliferation index as a prognostic marker in breast cancer

21 January 2018

1 reference

12 December 2020

Predictive value of HER-2 and Topoisomerase IIalpha in response to primary doxorubicin in breast cancer

1 reference

12 December 2020

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

1 reference

12 December 2020

Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)

1 reference

12 December 2020

Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival

1 reference

12 December 2020

Identifiers

DOI

10.1111/CAS.12245

1 reference

2 September 2017

1 reference